Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
Related Experiment Video
Updated: Jun 1, 2026

Intravitreal Injections in the Ovine Eye
Published on: July 5, 2022
1Department of Cornea and Anterior Segment, The Eye Super Specialities, Mumbai, India. urminikunj@hotmail.com
The purpose of the study was to report a case of choroidal neovascularization (CNV) secondary to ocular toxoplasmosis in an 18-year-old female patient. She was treated with a single intravitreal injection of ranibizumab. The CNV resolved as confirmed by fluorescein angiography and optical coherence tomography (OCT). The visual acuity improved to 20/30, which was maintained till the last follow-up visit at two years, without requisition of a repeat injection.
The purpose of the study was to report a case of choroidal neovascularization (CNV) secondary to ocular toxoplasmosis in an 18-year-old female patient. She was treated with a single intravitreal injection of ranibizumab. The CNV resolved as confirmed by fluorescein angiography and optical coherence tomography (OCT). The visual acuity improved to 20/30, which was maintained till the last follow-up visit at two years, without requisition of a repeat injection.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Toxoplasmosis
Diabetic Retinopathy
Glaucoma: Overview